Point Sur Investors

The Point Sur Investors LLC Fund I is a long-biased biotech sector fund with a two+ year track record. The Fund portfolio consists of small to mid-sized US-based, publicly traded, biopharmaceutical companies. Investments are only made in companies that are developing medicines that are tested in human clinical trials and have the potential to significantly advance the current standard of care. What Makes Us Different • We are at heart biotech operators and scientists, with experience in building and growing successful biotech programs. • We know what works and have accurately (93%) predicted clinical outcomes for our portfolio companies. • We have a defined research approach to analyze novel therapies. • We use disciplined buying and selling rules that guide our portfolio allocation. • ...and we truly love what we do.